Laporan Laba Rugi 524703 - TTM - Sandu Pharmaceuticals Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sandu Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	531	557	588	644	648	682	655	647	636	615	653	665	666	669	673	667	678	687	672	668
Change (%)		4.88	5.53	9.64	0.57	5.22	-3.92	-1.28	-1.69	-3.24	6.24	1.78	0.17	0.49	0.50	-0.91	1.65	1.41	-2.22	-0.52
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	332	344	363	376	378	408	378	357	345	307	333	340	335	347	346	324	344	346	321	316
Change (%)		3.60	5.78	3.52	0.41	8.12	-7.36	-5.54	-3.52	-10.93	8.38	2.09	-1.33	3.45	-0.13	-6.40	5.96	0.69	-7.20	-1.46
% of Revenue	62.46	61.70	61.85	58.39	58.30	59.90	57.76	55.26	54.24	49.93	50.93	51.09	50.33	51.81	51.49	48.64	50.70	50.34	47.78	47.32

Gross Operating Profit	199	213	224	268	270	273	277	289	291	308	321	325	331	323	326	342	334	341	351	352
Change (%)		7.01	5.12	19.57	0.80	1.17	1.23	4.54	0.56	5.88	4.11	1.45	1.73	-2.51	1.17	4.91	-2.44	2.15	2.82	0.34
% of Revenue	37.54	38.30	38.15	41.61	41.70	40.10	42.24	44.74	45.76	50.07	49.07	48.91	49.67	48.19	48.51	51.36	49.30	49.66	52.22	52.68

SG&A	118	133	118	87	132	123	139	143	143	148	170	169	169	166	178	99	177	183	109	113
Change (%)		12.57	-10.99	-26.52	51.60	-6.48	12.35	2.97	0.13	3.61	14.61	-0.35	-0.20	-1.94	7.45	-44.46	78.70	3.53	-40.26	3.07
% of Revenue	22.26	23.90	20.16	13.51	20.36	18.10	21.16	22.08	22.49	24.08	25.97	25.43	25.34	24.73	26.44	14.82	26.05	26.60	16.25	16.84

R&D
Change (%)
% of Revenue

OpEx	522	546	572	623	625	656	632	624	616	594	634	648	647	653	656	649	660	665	651	647
Change (%)		4.58	4.64	9.05	0.24	4.98	-3.71	-1.12	-1.43	-3.44	6.62	2.20	-0.18	1.00	0.40	-0.95	1.62	0.78	-2.13	-0.69
% of Revenue	98.37	98.10	97.27	96.75	96.43	96.21	96.42	96.58	96.84	96.64	96.99	97.39	97.05	97.55	97.45	97.41	97.39	96.79	96.88	96.72

Operating Income	9	11	16	21	23	26	23	22	20	21	20	17	20	16	17	17	18	22	21	22
Change (%)		22.63	51.36	30.72	10.48	11.71	-9.33	-5.68	-9.24	2.91	-4.63	-11.85	13.04	-16.33	4.29	0.84	2.52	24.75	-5.16	4.78
% of Revenue	1.63	1.90	2.73	3.25	3.57	3.79	3.58	3.42	3.16	3.36	3.01	2.61	2.95	2.45	2.55	2.59	2.61	3.21	3.12	3.28

Interest Expense	-2	-1	-1	-1	-1	-1	-1	-1	-0	-0	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Change (%)		-32.99	-50.22	26.28	31.82	-10.21	-23.57	-21.18	-43.52	48.33	47.75	1.04	-10.78	-1.85	-14.89	12.15	7.72	15.09	36.82	4.94
% of Revenue	-0.37	-0.23	-0.11	-0.13	-0.17	-0.14	-0.11	-0.09	-0.05	-0.08	-0.11	-0.11	-0.10	-0.10	-0.08	-0.09	-0.10	-0.11	-0.15	-0.16

Net Income	6	7	11	15	15	17	16	16	15	15	15	12	14	11	15	15	15	18	16	16
Change (%)		22.35	45.78	34.81	3.80	10.17	-5.64	-2.17	-4.44	2.20	0.14	-18.05	13.43	-19.46	28.37	3.94	-3.83	24.30	-14.54	3.63
% of Revenue	1.15	1.35	1.86	2.29	2.36	2.47	2.43	2.40	2.34	2.47	2.33	1.87	2.12	1.70	2.17	2.28	2.16	2.64	2.31	2.41

Source: Capital IQ

Sandu Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)